Bright Minds Biosciences Inc.

NASDAQ:DRUG

Biotechnology

Healthcare
$20.76 +1.04%

+$0.62 today

Market cap
$204.78M
Beta
-0.11
P/E (TTM)
-29.8
EPS (TTM)
-$2.87
52W Low $23.18High $123.75

Volume 0.14M

Average 0.27M

DRUG Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Bright Minds Biosciences Inc.NASDAQ: DRUG

Weighted Avg Shares · Q2 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q2 FY2026 weighted avg shares of 9.59M shares rose 114.9% year over year, ahead of the +77.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 23.6% from the prior quarter. Over 3 fiscal years it compounded at +40.7% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +114.9% holds above the trailing-twelve-month pace of +77.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
9.59M+23.6% QoQ
Last fiscal yearSep 2025
6.88M+59.6% YoY
LTMMar 2026
7.9M+77.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+114.9%——
1 year+59.6%——
3-year CAGR+40.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
6.88M CAD
Year-over-year change
+59.6%
4-year CAGR
+39.9%

Weighted Avg Shares vs competitors

How DRUG compares with its peers on the latest reported figures

No competitor Weighted Avg Shares figures are available to compare.

Income Statement

CAD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development6.31M12.18M5M1.18M11.08M
Selling, General & Admin2.31M2.55M2.2M1.45M2.57M
Operating Expenses8.62M14.98M7.39M2.82M13.94M
Depreciation & Amortization8.62M6.04K72.45K73.36K76.87K
EBITDA(27.64K)(14.96M)(7.3M)(2.73M)(12.15M)
EBITDA Margin—————
Operating Income(8.62M)(14.98M)(7.39M)(2.82M)(13.94M)
Operating Margin—————
Interest Income00030.13K1.52M
Interest Expense00000
Other Income / Expenses(27.64K)10.15K14.19K20.82K1.71M
Income Before Tax(8.65M)(14.96M)(7.37M)(2.8M)(12.23M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(8.65M)(14.96M)(7.37M)(2.8M)(12.23M)
Net Margin—————
EPS (Basic)(4.74)(6.15)(1.98)(0.65)(1.78)
EPS (Diluted)(4.74)(6.15)(1.98)(0.65)(1.78)
Weighted Avg Shares1.79M2.47M3.72M4.31M6.88M
Weighted Avg Shares (Diluted)1.79M2.47M3.72M4.31M6.88M

Bright Minds Biosciences Inc.

NASDAQ:DRUG

Intrinsic Alpha fair value

Locked

Current Price

$20.76

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.